These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 12752526)

  • 1. Botulinum toxin type A in the treatment of bilateral primary axillary hyperhidrosis: efficacy and duration with repeated treatments.
    Lowe PL; Cerdan-Sanz S; Lowe NJ
    Dermatol Surg; 2003 May; 29(5):545-8. PubMed ID: 12752526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study.
    Naumann M; Lowe NJ; Kumar CR; Hamm H;
    Arch Dermatol; 2003 Jun; 139(6):731-6. PubMed ID: 12810503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial.
    Naumann M; Lowe NJ
    BMJ; 2001 Sep; 323(7313):596-9. PubMed ID: 11557704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients.
    Schnider P; Moraru E; Kittler H; Binder M; Kranz G; Voller B; Auff E
    Br J Dermatol; 2001 Aug; 145(2):289-93. PubMed ID: 11531794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of botulinum toxin type A on quality of life measures in patients with excessive axillary sweating: a randomized controlled trial.
    Naumann MK; Hamm H; Lowe NJ;
    Br J Dermatol; 2002 Dec; 147(6):1218-26. PubMed ID: 12452874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dilution of botulinum toxin A in lidocaine vs. in normal saline for the treatment of primary axillary hyperhidrosis: a double-blind, randomized, comparative preliminary study.
    Güleç AT
    J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):314-8. PubMed ID: 21492253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosis.
    Baumann L; Slezinger A; Halem M; Vujevich J; Martin LK; Black L; Bryde J
    Int J Dermatol; 2005 May; 44(5):418-24. PubMed ID: 15869543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of focal idiopathic hyperhidrosis with Botulinum Toxin Type A: clinical predictive factors of relapse-free survival.
    Campanati A; Sandroni L; Gesuita R; Giuliano A; Giuliodori K; Marconi B; Ganzetti G; Offidani A
    J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):917-21. PubMed ID: 21054569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Same-patient prospective comparison of Botox versus Dysport for the treatment of primary axillary hyperhidrosis and review of literature.
    Vergilis-Kalner IJ
    J Drugs Dermatol; 2011 Sep; 10(9):1013-5. PubMed ID: 22052270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term quantitative benefits of botulinum toxin type A in the treatment of axillary hyperhidrosis.
    Odderson IR
    Dermatol Surg; 2002 Jun; 28(6):480-3. PubMed ID: 12081675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin in the treatment of axillary hyperhidrosis.
    Galadari I; Alkaabi J
    Skinmed; 2003; 2(4):209-11. PubMed ID: 14673273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of axillary hyperhidrosis with botulinum-A toxin.
    Salmanpoor R; Rahmanian MJ
    Int J Dermatol; 2002 Jul; 41(7):428-30. PubMed ID: 12121560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A preliminary study of painless and effective transdermal botulinum toxin A delivery by jet nebulization for treatment of primary hyperhidrosis.
    Iannitti T; Palmieri B; Aspiro A; Di Cerbo A
    Drug Des Devel Ther; 2014; 8():931-5. PubMed ID: 25075176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and prolonged efficacy of Botulin Toxin A in primary hyperhidrosis.
    D'Epiro S; Macaluso L; Salvi M; Luci C; Mattozzi C; Marzocca F; Salvo V; Scarnò M; Calvieri S; Richetta AG
    Clin Ter; 2014; 165(6):e395-400. PubMed ID: 25524193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axillary hyperhidrosis: treatment with botulinum toxin A.
    Odderson IR
    Arch Phys Med Rehabil; 1998 Mar; 79(3):350-2. PubMed ID: 9523792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duration of efficacy increases with the repetition of botulinum toxin A injections in primary axillary hyperhidrosis: a study in 83 patients.
    Lecouflet M; Leux C; Fenot M; Célerier P; Maillard H
    J Am Acad Dermatol; 2013 Dec; 69(6):960-4. PubMed ID: 24035554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repetitive injections of botulinum toxin A continuously increase the duration of efficacy in primary axillary hyperhidrosis: a retrospective analysis in 101 patients.
    Brehmer F; Lockmann A; Grönemeyer LL; Kretschmer L; Schön MP; Thoms KM
    J Dtsch Dermatol Ges; 2015 Aug; 13(8):799-805. PubMed ID: 26176740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective evaluation of the efficacy of dermal botulinium toxin for primary axillary hyperhidrosis.
    Hanlon L; Cahill R; Barry MC
    Ir J Med Sci; 2006; 175(1):57-8. PubMed ID: 16615232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palmar and axillary hyperhidrosis treated with botulinum toxin: one-year clinical follow-up.
    Naver H; Swartling C; Aquilonius SM
    Eur J Neurol; 2000 Jan; 7(1):55-62. PubMed ID: 10809915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of Botulinum Toxin A in Axillary Bromhidrosis and Associated Histological Changes in Sweat Glands: A Prospective Randomized Double-Blind Side-by-Side Comparison Clinical Study.
    Wu CJ; Chang CK; Wang CY; Liao YS; Chen SG
    Dermatol Surg; 2019 Dec; 45(12):1605-1609. PubMed ID: 30829777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.